US company Kimberly-Clark buys Tylenol maker Kenvue

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal, creating a massive consumer health goods company.

In the deal worth about $US48.7 billion ($A74.5 billion),…